IMMUNOPOTENTIATING FORMULATIONS FOR VACCINAL USE
The present invention relates to the medical field, particularly to the use of new formulations of adjuvants as vaccinal antigenes. The technical objective of the present invention is precisely the development of formulations capable of raising and/or modulating the immune response of the organism t...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MESA PARDILLO, CIRSE MADRAZO PINOL, JUAN JOEL HECHAVARRIA GAY, MAYDEL CRUZ RICONDO, LUIS JAVIER PENTON ARIAS, EDUARDO CARMENATE PORTILLA, TANIA IGLESIAS PEREZ, ENRIQUE GUILLEN NIETO, GERARDO ENRIQUE PICHARDO DIAZ, DAGMARA LEAL ANGULO, MARIA DE JESUS VELIZ RIOS, GLORIA MUZIO GONZALEZ, VERENA LUCILA AGUILAR RUBIDO, JULIO CESAR HERRERA BUCH, ANTONIETA DIAZ MARTINEZ, MAYLIN |
| description | The present invention relates to the medical field, particularly to the use of new formulations of adjuvants as vaccinal antigenes. The technical objective of the present invention is precisely the development of formulations capable of raising and/or modulating the immune response of the organism to vaccinal antigenes at serum and mucus levels. In order to attain such objective, a formulation has been developed which contains as fundamental components the surface antigene of the B hepatitis virus and the acemanane in adequate proportions. As an extension of such result, formulations have been developed wherein: a) HBsAg is used as carrier of homologous and heterologous antigenes; b) systems for transmitting particulate antigens and c) soluble antigens, in combination with the acemanane in specific proportions. The formulations of this invention are applicable to the pharmaceutical industry as vaccinal formulations both for human and veterinary use. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2283344A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2283344A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2283344A13</originalsourceid><addsrcrecordid>eNrjZDDw9PUN9fMP8A9x9QvxdAzx9HNXcPMP8g31AbL9_YJBHIUwR2dnTz9HH4XQYFceBta0xJziVF4ozc2g4OYa4uyhm1qQH59aXJCYnJqXWhLv7GhkZGFsbGLiaGhMhBIAG58mNA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>IMMUNOPOTENTIATING FORMULATIONS FOR VACCINAL USE</title><source>esp@cenet</source><creator>MESA PARDILLO, CIRSE ; MADRAZO PINOL, JUAN JOEL ; HECHAVARRIA GAY, MAYDEL ; CRUZ RICONDO, LUIS JAVIER ; PENTON ARIAS, EDUARDO ; CARMENATE PORTILLA, TANIA ; IGLESIAS PEREZ, ENRIQUE ; GUILLEN NIETO, GERARDO ENRIQUE ; PICHARDO DIAZ, DAGMARA ; LEAL ANGULO, MARIA DE JESUS ; VELIZ RIOS, GLORIA ; MUZIO GONZALEZ, VERENA LUCILA ; AGUILAR RUBIDO, JULIO CESAR ; HERRERA BUCH, ANTONIETA ; DIAZ MARTINEZ, MAYLIN</creator><creatorcontrib>MESA PARDILLO, CIRSE ; MADRAZO PINOL, JUAN JOEL ; HECHAVARRIA GAY, MAYDEL ; CRUZ RICONDO, LUIS JAVIER ; PENTON ARIAS, EDUARDO ; CARMENATE PORTILLA, TANIA ; IGLESIAS PEREZ, ENRIQUE ; GUILLEN NIETO, GERARDO ENRIQUE ; PICHARDO DIAZ, DAGMARA ; LEAL ANGULO, MARIA DE JESUS ; VELIZ RIOS, GLORIA ; MUZIO GONZALEZ, VERENA LUCILA ; AGUILAR RUBIDO, JULIO CESAR ; HERRERA BUCH, ANTONIETA ; DIAZ MARTINEZ, MAYLIN</creatorcontrib><description>The present invention relates to the medical field, particularly to the use of new formulations of adjuvants as vaccinal antigenes. The technical objective of the present invention is precisely the development of formulations capable of raising and/or modulating the immune response of the organism to vaccinal antigenes at serum and mucus levels. In order to attain such objective, a formulation has been developed which contains as fundamental components the surface antigene of the B hepatitis virus and the acemanane in adequate proportions. As an extension of such result, formulations have been developed wherein: a) HBsAg is used as carrier of homologous and heterologous antigenes; b) systems for transmitting particulate antigens and c) soluble antigens, in combination with the acemanane in specific proportions. The formulations of this invention are applicable to the pharmaceutical industry as vaccinal formulations both for human and veterinary use.</description><edition>6</edition><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>1998</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19980911&DB=EPODOC&CC=CA&NR=2283344A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19980911&DB=EPODOC&CC=CA&NR=2283344A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MESA PARDILLO, CIRSE</creatorcontrib><creatorcontrib>MADRAZO PINOL, JUAN JOEL</creatorcontrib><creatorcontrib>HECHAVARRIA GAY, MAYDEL</creatorcontrib><creatorcontrib>CRUZ RICONDO, LUIS JAVIER</creatorcontrib><creatorcontrib>PENTON ARIAS, EDUARDO</creatorcontrib><creatorcontrib>CARMENATE PORTILLA, TANIA</creatorcontrib><creatorcontrib>IGLESIAS PEREZ, ENRIQUE</creatorcontrib><creatorcontrib>GUILLEN NIETO, GERARDO ENRIQUE</creatorcontrib><creatorcontrib>PICHARDO DIAZ, DAGMARA</creatorcontrib><creatorcontrib>LEAL ANGULO, MARIA DE JESUS</creatorcontrib><creatorcontrib>VELIZ RIOS, GLORIA</creatorcontrib><creatorcontrib>MUZIO GONZALEZ, VERENA LUCILA</creatorcontrib><creatorcontrib>AGUILAR RUBIDO, JULIO CESAR</creatorcontrib><creatorcontrib>HERRERA BUCH, ANTONIETA</creatorcontrib><creatorcontrib>DIAZ MARTINEZ, MAYLIN</creatorcontrib><title>IMMUNOPOTENTIATING FORMULATIONS FOR VACCINAL USE</title><description>The present invention relates to the medical field, particularly to the use of new formulations of adjuvants as vaccinal antigenes. The technical objective of the present invention is precisely the development of formulations capable of raising and/or modulating the immune response of the organism to vaccinal antigenes at serum and mucus levels. In order to attain such objective, a formulation has been developed which contains as fundamental components the surface antigene of the B hepatitis virus and the acemanane in adequate proportions. As an extension of such result, formulations have been developed wherein: a) HBsAg is used as carrier of homologous and heterologous antigenes; b) systems for transmitting particulate antigens and c) soluble antigens, in combination with the acemanane in specific proportions. The formulations of this invention are applicable to the pharmaceutical industry as vaccinal formulations both for human and veterinary use.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1998</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDDw9PUN9fMP8A9x9QvxdAzx9HNXcPMP8g31AbL9_YJBHIUwR2dnTz9HH4XQYFceBta0xJziVF4ozc2g4OYa4uyhm1qQH59aXJCYnJqXWhLv7GhkZGFsbGLiaGhMhBIAG58mNA</recordid><startdate>19980911</startdate><enddate>19980911</enddate><creator>MESA PARDILLO, CIRSE</creator><creator>MADRAZO PINOL, JUAN JOEL</creator><creator>HECHAVARRIA GAY, MAYDEL</creator><creator>CRUZ RICONDO, LUIS JAVIER</creator><creator>PENTON ARIAS, EDUARDO</creator><creator>CARMENATE PORTILLA, TANIA</creator><creator>IGLESIAS PEREZ, ENRIQUE</creator><creator>GUILLEN NIETO, GERARDO ENRIQUE</creator><creator>PICHARDO DIAZ, DAGMARA</creator><creator>LEAL ANGULO, MARIA DE JESUS</creator><creator>VELIZ RIOS, GLORIA</creator><creator>MUZIO GONZALEZ, VERENA LUCILA</creator><creator>AGUILAR RUBIDO, JULIO CESAR</creator><creator>HERRERA BUCH, ANTONIETA</creator><creator>DIAZ MARTINEZ, MAYLIN</creator><scope>EVB</scope></search><sort><creationdate>19980911</creationdate><title>IMMUNOPOTENTIATING FORMULATIONS FOR VACCINAL USE</title><author>MESA PARDILLO, CIRSE ; MADRAZO PINOL, JUAN JOEL ; HECHAVARRIA GAY, MAYDEL ; CRUZ RICONDO, LUIS JAVIER ; PENTON ARIAS, EDUARDO ; CARMENATE PORTILLA, TANIA ; IGLESIAS PEREZ, ENRIQUE ; GUILLEN NIETO, GERARDO ENRIQUE ; PICHARDO DIAZ, DAGMARA ; LEAL ANGULO, MARIA DE JESUS ; VELIZ RIOS, GLORIA ; MUZIO GONZALEZ, VERENA LUCILA ; AGUILAR RUBIDO, JULIO CESAR ; HERRERA BUCH, ANTONIETA ; DIAZ MARTINEZ, MAYLIN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2283344A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>1998</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>MESA PARDILLO, CIRSE</creatorcontrib><creatorcontrib>MADRAZO PINOL, JUAN JOEL</creatorcontrib><creatorcontrib>HECHAVARRIA GAY, MAYDEL</creatorcontrib><creatorcontrib>CRUZ RICONDO, LUIS JAVIER</creatorcontrib><creatorcontrib>PENTON ARIAS, EDUARDO</creatorcontrib><creatorcontrib>CARMENATE PORTILLA, TANIA</creatorcontrib><creatorcontrib>IGLESIAS PEREZ, ENRIQUE</creatorcontrib><creatorcontrib>GUILLEN NIETO, GERARDO ENRIQUE</creatorcontrib><creatorcontrib>PICHARDO DIAZ, DAGMARA</creatorcontrib><creatorcontrib>LEAL ANGULO, MARIA DE JESUS</creatorcontrib><creatorcontrib>VELIZ RIOS, GLORIA</creatorcontrib><creatorcontrib>MUZIO GONZALEZ, VERENA LUCILA</creatorcontrib><creatorcontrib>AGUILAR RUBIDO, JULIO CESAR</creatorcontrib><creatorcontrib>HERRERA BUCH, ANTONIETA</creatorcontrib><creatorcontrib>DIAZ MARTINEZ, MAYLIN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MESA PARDILLO, CIRSE</au><au>MADRAZO PINOL, JUAN JOEL</au><au>HECHAVARRIA GAY, MAYDEL</au><au>CRUZ RICONDO, LUIS JAVIER</au><au>PENTON ARIAS, EDUARDO</au><au>CARMENATE PORTILLA, TANIA</au><au>IGLESIAS PEREZ, ENRIQUE</au><au>GUILLEN NIETO, GERARDO ENRIQUE</au><au>PICHARDO DIAZ, DAGMARA</au><au>LEAL ANGULO, MARIA DE JESUS</au><au>VELIZ RIOS, GLORIA</au><au>MUZIO GONZALEZ, VERENA LUCILA</au><au>AGUILAR RUBIDO, JULIO CESAR</au><au>HERRERA BUCH, ANTONIETA</au><au>DIAZ MARTINEZ, MAYLIN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>IMMUNOPOTENTIATING FORMULATIONS FOR VACCINAL USE</title><date>1998-09-11</date><risdate>1998</risdate><abstract>The present invention relates to the medical field, particularly to the use of new formulations of adjuvants as vaccinal antigenes. The technical objective of the present invention is precisely the development of formulations capable of raising and/or modulating the immune response of the organism to vaccinal antigenes at serum and mucus levels. In order to attain such objective, a formulation has been developed which contains as fundamental components the surface antigene of the B hepatitis virus and the acemanane in adequate proportions. As an extension of such result, formulations have been developed wherein: a) HBsAg is used as carrier of homologous and heterologous antigenes; b) systems for transmitting particulate antigens and c) soluble antigens, in combination with the acemanane in specific proportions. The formulations of this invention are applicable to the pharmaceutical industry as vaccinal formulations both for human and veterinary use.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA2283344A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | IMMUNOPOTENTIATING FORMULATIONS FOR VACCINAL USE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T15%3A02%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MESA%20PARDILLO,%20CIRSE&rft.date=1998-09-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2283344A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |